slotkoers
Ljubljana S.E.
00:00:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
125,5
EUR
|
+0,40%
|
|
-0,40%
|
+14,09%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
2.320
|
2.862
|
3.676
|
2.857
|
3.402
|
3.869
|
-
|
-
|
Bedrijfswaarde
1 |
2.101
|
2.558
|
3.373
|
2.338
|
3.228
|
3.355
|
3.326
|
3.089
|
K/w-verhouding
|
9,47
x
|
9,86
x
|
11,9
x
|
7,87
x
|
10,8
x
|
11,6
x
|
11,1
x
|
10,6
x
|
Dividendrendement
|
4,37%
|
5,47%
|
4,24%
|
6,12%
|
6%
|
5,56%
|
5,83%
|
5,99%
|
Marktkapitalisatie/omzet
|
1,55
x
|
1,86
x
|
2,35
x
|
1,66
x
|
1,88
x
|
2,06
x
|
1,98
x
|
1,87
x
|
Bedrijfswaarde/omzet
|
1,41
x
|
1,67
x
|
2,15
x
|
1,36
x
|
1,79
x
|
1,79
x
|
1,7
x
|
1,49
x
|
Bedrijfswaarde/EBITDA
|
5,45
x
|
5,09
x
|
7,27
x
|
4,78
x
|
6,4
x
|
6,47
x
|
6,13
x
|
5,63
x
|
Bedrijfswaarde/FCF
|
9,35
x
|
10,2
x
|
10,5
x
|
6,27
x
|
36,7
x
|
12,2
x
|
11,3
x
|
9,81
x
|
FCF Yield
|
10,7%
|
9,82%
|
9,49%
|
16%
|
2,73%
|
8,22%
|
8,83%
|
10,2%
|
Price to Book
|
1,44
x
|
1,64
x
|
2,02
x
|
1,41
x
|
1,65
x
|
1,8
x
|
1,69
x
|
-
|
Aantal aandelen (in duizenden)
|
31.690
|
31.313
|
31.152
|
31.052
|
30.925
|
30.832
|
-
|
-
|
Referentieprijs
2 |
73,20
|
91,40
|
118,0
|
92,00
|
110,0
|
125,5
|
125,5
|
125,5
|
Datum van publicatie
|
19/03/20
|
18/03/21
|
17/03/22
|
13/04/23
|
14/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
1.493
|
1.535
|
1.566
|
1.717
|
1.806
|
1.874
|
1.956
|
2.068
|
EBITDA
1 |
385,4
|
502,4
|
463,6
|
488,9
|
504,2
|
518,6
|
542,2
|
549,1
|
Bedrijfsresultaat (EBIT)
1 |
274,2
|
390,7
|
354,8
|
381,2
|
399,6
|
406,9
|
420,5
|
435,6
|
Operationele Marge
|
18,36%
|
25,46%
|
22,66%
|
22,2%
|
22,12%
|
21,71%
|
21,5%
|
21,06%
|
Resultaat voor belastingen (EBT)
1 |
284,4
|
339
|
362,4
|
433,1
|
367,1
|
409
|
425,5
|
422,5
|
Nettowinst (verlies)
1 |
245,5
|
291
|
309,2
|
363,3
|
313,9
|
343,4
|
358,6
|
369,1
|
Nettomarge
|
16,44%
|
18,96%
|
19,75%
|
21,15%
|
17,38%
|
18,32%
|
18,34%
|
17,84%
|
WPA
2 |
7,730
|
9,270
|
9,920
|
11,69
|
10,14
|
10,81
|
11,31
|
11,82
|
Free Cash Flow
1 |
224,7
|
251,2
|
320,2
|
372,9
|
88,04
|
275,8
|
293,5
|
314,9
|
FCF-marge
|
15,05%
|
16,36%
|
20,45%
|
21,71%
|
4,87%
|
14,71%
|
15,01%
|
15,22%
|
Kasstroomconversie (ebitda)
|
58,3%
|
49,99%
|
69,06%
|
76,28%
|
17,46%
|
53,18%
|
54,14%
|
57,35%
|
Kasstroomconversie (nettowinst)
|
91,52%
|
86,31%
|
103,55%
|
102,65%
|
28,04%
|
80,31%
|
81,85%
|
85,32%
|
Dividend per aandeel
2 |
3,200
|
5,000
|
5,000
|
5,630
|
6,600
|
6,982
|
7,320
|
7,520
|
Datum van publicatie
|
19/03/20
|
18/03/21
|
17/03/22
|
13/04/23
|
14/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
219
|
304
|
303
|
519
|
174
|
515
|
543
|
781
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
225
|
251
|
320
|
373
|
88
|
276
|
294
|
315
|
ROE (netto-inkomsten/eigen vermogen)
|
15,2%
|
17,1%
|
17%
|
17,9%
|
14,5%
|
15,1%
|
14,9%
|
14,5%
|
ROA (netto-inkomsten/totale activa)
|
-
|
-
|
13%
|
13,9%
|
11,5%
|
11,7%
|
11,8%
|
11,3%
|
Totale activa
1 |
-
|
-
|
2.387
|
2.614
|
2.730
|
2.935
|
3.039
|
3.266
|
Nettoactief per aandeel
2 |
50,90
|
55,80
|
58,50
|
65,20
|
66,50
|
69,80
|
74,20
|
-
|
Cashflow per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
111
|
80,8
|
72,1
|
94,7
|
139
|
144
|
144
|
143
|
Capex/omzet
|
7,41%
|
5,27%
|
4,61%
|
5,52%
|
7,71%
|
7,69%
|
7,35%
|
6,92%
|
Datum van publicatie
|
19/03/20
|
18/03/21
|
17/03/22
|
13/04/23
|
14/03/24
|
-
|
-
|
-
|
Laatste slotkoers
125,5
EUR Gemiddelde koersdoel
133,6
EUR Spread / Gemiddelde doel +6,49% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +14,09% | 4,13 mld. | | +19,62% | 43,34 mld. | | +20,44% | 21,96 mld. | | +10,86% | 14,09 mld. | | +13,07% | 13,64 mld. | | +37,46% | 11,43 mld. | | -8,59% | 6,86 mld. | | -0,05% | 6,79 mld. | | -8,87% | 5,73 mld. | | +8,46% | 5,22 mld. |
Generieke geneesmiddelen
|